Belkyra (or Kybella as it is known in the US) treatment is not available in Singapore at the moment. The parent company Allergan is only targeted to launch the product in Singapore in 2020.
With regards to its safety profile, Belkyra is a HSA registered and approved medication since June 2018, for use in the treatment of moderate to severe convexity or fullness associated with fat below the chin( submental fat) in adults above 18 years of age.
It is important to note that the downtime and results from the treatment vary between individuals. Other options for the treatment of submental fat also include cryolipolysis(fat freezing) and of course surgical liposuction.
Hope this clarifies!
Thank you and have a nice day !
